IFF Explores the Science Behind Well-Being at In‑Cosmetics Global 2026
IFF Explores the Science Behind Well-Being at In‑Cosmetics Global 2026
Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Very Positive)
Tags
Key Terms
neurosciencemedical
Neuroscience is the scientific study of the nervous system, especially the brain, spinal cord and networks of nerves that control thought, movement and bodily functions. For investors it matters because advances in this field drive new medicines, medical devices, diagnostics and computing technologies; like improving an operating manual for the body and mind, breakthroughs can create big commercial opportunities, regulatory hurdles, patent value and binary clinical risks that affect company valuation.
ai-guidedtechnical
AI-guided describes decisions, processes or products that are directed or assisted by artificial intelligence systems rather than relying solely on human judgment. Think of it like a GPS for a business process: the software analyzes large amounts of data to suggest routes, optimize timing, or flag problems. For investors, AI-guided claims signal potential for faster, cheaper or more consistent outcomes—but also introduce dependence on models and data quality, which affects risk and value.
adaptogenicmedical
Adaptogenic describes herbs, mushrooms or supplements marketed as helping the body cope with physical or mental stress and restore balance, like a shock absorber or thermostat for the body’s responses. It matters to investors because products labeled adaptogenic can drive consumer demand and premium pricing, but claims often face varying levels of scientific support and regulatory scrutiny, which can affect sales, labeling risk and company valuation.
nootropicmedical
A nootropic is a drug, supplement or compound sold with the claim that it improves thinking skills such as memory, focus, creativity or mental energy. For investors it matters because demand, scientific evidence, safety and regulatory approval determine whether products actually sell and sustain profits—think of a nootropic like a software update promising faster performance: if the upgrade works and is allowed, the maker can gain market share; if it fails or is restricted, value can fall.
bioactivemedical
A bioactive is a substance that produces a measurable effect on living cells, tissues, or organisms—ranging from nutrients and plant compounds to drugs and biologics. Investors care because bioactive ingredients determine a product’s therapeutic potential, safety profile and regulatory requirements, which in turn influence market approval, consumer demand and revenue; think of a bioactive as the engine that makes a health product actually work.
biotech-enabledtechnical
Describes products, services, or companies that use biological science—such as engineered cells, molecules, lab techniques, or biological data—together with non‑biological tools like software, instruments, or conventional manufacturing to create or improve offerings. It matters to investors because combining biology with other technologies can boost innovation and create new revenue paths, but also brings specific scientific, regulatory and commercialization risks; think of it as adding a powerful new engine to an existing vehicle that can improve performance but changes how the vehicle must be maintained and tested.
polymertechnical
A polymer is a large molecule made of many repeating building blocks, like beads on a string, that can be natural (e.g., rubber, cellulose) or man‑made (e.g., plastics, synthetic fibers). Investors care because polymers are the raw material behind countless products and industries; changes in feedstock costs, supply, regulation, or technical improvements can quickly affect a manufacturer’s margins, product demand, and company value.
biosciencesmedical
Biosciences are the fields of science that study living things, from cells and genes to whole organisms and how they respond to drugs or environments. For investors, biosciences matter because companies in this area develop new medicines, diagnostics, and technologies that can drive revenue growth or regulatory risk; think of them as firms turning biological discovery into products the market may adopt, with outcomes that can sharply change a company's value.
See more from StockTitan in Google Search and AI answers.Adds StockTitan as a preferred source · opens Google
Showcasing the latest in wellness-driven, eco-friendly scent innovations
PARIS, France--(BUSINESS WIRE)--
IFF (NYSE: IFF)—a global leader in flavors, fragrances, food ingredients and health & biosciences—will showcase scent and bioscience innovations focused on wellness and sustainability at In‑Cosmetics Global 2026, taking place April 14–16 at the Paris Expo Porte de Versailles.
IFF showcases wellness innovation for beauty.
Across the event, including experiences and live sessions, IFF will illustrate how science‑led ingredients can enhance daily beauty routines and scent experiences, delivering physical and emotional benefits while remaining ecofriendly. The showcase will span scent solutions designed to support science-based wellness; natural fragrance ingredients with proven cosmetic benefits by LMR—IFF’s in‑house natural ingredients capability—derived through advanced extraction technologies; and sustainable, bioactive and functional ingredients for skin and hair care.
Visitors can discover scent solutions designed with METAMOOD™—which combines consumer perception data, neuroscience and AI-guided creation to deliver emotional benefits such as energy, relaxation and happiness—at the IFF booth and METAMOOD™ X LMR Sensory Bar Display within the In-Cosmetics Innovation Lab.
In-Cosmetics attendees can also experience natural fragrance ingredients from the LMR Active Essences collection, known for adaptogenic and nootropic benefits and scientifically proven skin care and hair care properties.
Additionally, IFF will highlight its METASLEEP™ scent solutions, designed to enhance relaxation and support a restful sleep experience.
On April 15, IFF Application Specialist Morgane Piet will deliver a technical seminar to share insight into how consumers experience hair care products across the full journey, from first impressions to post-use. IFF will demonstrate how AURIST™ AGC, IFF’s award‑winning, biotech‑enabled hair conditioning polymer powered by IFF’s Designed Enzymatic Biomaterials™ (DEB), can be used as a formulation tool to deliver targeted sensory and performance benefits.
IFF will also host a live session over three days, sharing real-world consumer usage insights and highlighting how IFF’s GENENCARE® range creates new formulation opportunities for brands navigating modern skin care routines.
At In-Cosmetics Global 2026, IFF will bring science, sensorial design and performance together to demonstrate consumer‑driven innovations that deliver wellness benefits. Across booth experiences and live sessions, IFF’s Science of Wellness program will come to life through scents designed to elevate mood and spark moments of joy—elevating the power of beauty.
Welcome to IFF
At IFF (NYSE: IFF), we make joy through science, creativity and heart. As the global leader in taste, scent, food ingredients, health and biosciences, we’re innovating for the future. Every day, we deliver groundbreaking, sustainable solutions that elevate products people love — advancing wellness, delighting the senses and enhancing the human experience. Learn more at iff.com, LinkedIn, Instagram and Facebook.
LMR Naturals by IFF
LMR is an IFF in-house capability which brings together the best of nature and cutting-edge technology to craft a wide range of pure ingredients for perfumery, cosmetics and flavors. Headquartered in Grasse, its agronomists and scientists travel the world to uncover, farm, harvest and extract the highest quality of natural ingredients that make the signature of unforgettable fragrances, cosmetics, and flavors. Learn more at lmrnaturals.iff.com, LinkedIn, and Instagram.
